News

Study Explores Challenges of Treating Myeloma in the Elderly

The diagnosis and management of myeloma in the very elderly is especially challenging, despite improvements in therapies. A review study, “Multiple myeloma in the very elderly patient: challenges and solutions, published in Clinical Interventions in Aging, suggested ways of overcoming the difficulties to maximize these patients’ length and quality of life. New drug development has…

MedImmune’s Antibody Therapy Seen to Effectively Reduce Cancer Stem Cells in Most Newly Diagnosed Multiple Myeloma Patients

A research team led by William Matsui, MD, and Carol Ann Huff, MD, with the Johns Hopkins Kimmel Cancer Center, has found that MedImmune’s novel MEDI-551 antibody treatment effectively decreased the number of cancer stem cells, which drive the growth of cancer, in most patients with recently diagnosed multiple myeloma. Study results will be…

First Large-Scale Screening Aims to Prevent Myeloma Before Onset

A screening study — the largest of its kind for myeloma — hopes to find a way to prevent myeloma before it develops. The study, called iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma), was announced by the International Myeloma Foundation (IMF), which is funding the research. The organization is the largest…